Company / Gross Profit per Share
Sonoma Pharmaceuticals, Inc. Gross Profit per Share History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$3.34
FY2026
5-year range
$0.91 / $6.08
FY2022-FY2026
Trend
-45.0%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share has fluctuated over the past 10 years, ranging from $0.63 in FY2017 to $10.66 in FY2019.
Based on SEC 10-K filings.
3.34 in FY2026 with a 5-year CAGR of -6.1%.
Improved from $0.91 to $3.34 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +37.5%
- 5-Year CAGR
- -6.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2026, gross profit per share decreased 45.0% year-over-year.
- Peak gross profit per share was recorded in FY2019.
- Lowest gross profit per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $3.34 | -45.0% |
| FY2025 | $6.08 | +570.1% |
| FY2024 | $0.91 | -29.5% |
| FY2023 | $1.29 | -58.9% |
| FY2022 | $3.13 | -31.4% |
| FY2021 | $4.57 | -32.3% |
| FY2020 | $6.75 | -36.7% |
| FY2019 | $10.66 | +706.7% |
| FY2018 | $1.32 | +109.4% |
| FY2017 | $0.63 | +30.3% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026